BNP Paribas Financial Markets increased its stake in Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 73.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 208,983 shares of the real estate investment trust's stock after acquiring an additional 88,220 shares during the period. BNP Paribas Financial Markets owned approximately 0.09% of Sabra Health Care REIT worth $3,889,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Principal Financial Group Inc. raised its position in Sabra Health Care REIT by 0.8% in the 3rd quarter. Principal Financial Group Inc. now owns 21,573,436 shares of the real estate investment trust's stock valued at $401,479,000 after purchasing an additional 167,069 shares in the last quarter. Charles Schwab Investment Management Inc. increased its stake in shares of Sabra Health Care REIT by 8.4% during the third quarter. Charles Schwab Investment Management Inc. now owns 4,701,881 shares of the real estate investment trust's stock worth $87,502,000 after buying an additional 365,855 shares during the period. LSV Asset Management raised its holdings in Sabra Health Care REIT by 2.5% in the second quarter. LSV Asset Management now owns 4,380,815 shares of the real estate investment trust's stock valued at $67,465,000 after acquiring an additional 104,800 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in Sabra Health Care REIT by 3.8% in the second quarter. Dimensional Fund Advisors LP now owns 3,394,562 shares of the real estate investment trust's stock worth $52,275,000 after acquiring an additional 124,825 shares during the last quarter. Finally, APG Asset Management US Inc. lifted its position in shares of Sabra Health Care REIT by 28.9% during the 2nd quarter. APG Asset Management US Inc. now owns 2,562,962 shares of the real estate investment trust's stock worth $39,495,000 after purchasing an additional 575,000 shares during the last quarter. 99.40% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
SBRA has been the topic of a number of analyst reports. Citigroup upgraded Sabra Health Care REIT from a "neutral" rating to a "buy" rating and raised their price target for the company from $17.00 to $20.00 in a research note on Friday, September 13th. Mizuho reissued a "neutral" rating and set a $20.00 target price on shares of Sabra Health Care REIT in a research report on Thursday. Truist Financial upped their price target on Sabra Health Care REIT from $16.00 to $18.00 and gave the company a "buy" rating in a report on Wednesday, September 4th. Scotiabank raised their price objective on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a "sector perform" rating in a report on Friday, October 11th. Finally, Wells Fargo & Company upgraded shares of Sabra Health Care REIT from an "equal weight" rating to an "overweight" rating and upped their target price for the company from $16.00 to $20.00 in a report on Tuesday, October 1st. Two equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $19.14.
View Our Latest Analysis on SBRA
Sabra Health Care REIT Stock Performance
Shares of SBRA stock traded down $0.17 during trading hours on Thursday, hitting $18.26. The stock had a trading volume of 1,574,346 shares, compared to its average volume of 2,037,052. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.16 and a quick ratio of 4.16. The firm has a market capitalization of $4.32 billion, a PE ratio of 44.95, a PEG ratio of 2.32 and a beta of 1.24. The stock's 50 day moving average is $18.61 and its 200 day moving average is $16.92. Sabra Health Care REIT, Inc. has a twelve month low of $12.83 and a twelve month high of $20.03.
Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last issued its quarterly earnings results on Thursday, October 31st. The real estate investment trust reported $0.13 earnings per share for the quarter, missing analysts' consensus estimates of $0.35 by ($0.22). Sabra Health Care REIT had a return on equity of 3.51% and a net margin of 14.20%. The business had revenue of $178.00 million for the quarter, compared to analyst estimates of $177.19 million. During the same quarter in the prior year, the company earned $0.34 EPS. As a group, research analysts forecast that Sabra Health Care REIT, Inc. will post 1.39 earnings per share for the current fiscal year.
Sabra Health Care REIT Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, November 29th. Shareholders of record on Friday, November 15th were paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 6.57%. The ex-dividend date of this dividend was Friday, November 15th. Sabra Health Care REIT's dividend payout ratio is presently 292.69%.
Sabra Health Care REIT Company Profile
(
Free Report)
As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.
Featured Articles
Before you consider Sabra Health Care REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Health Care REIT wasn't on the list.
While Sabra Health Care REIT currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.